Transient Neurologic Dysfunction in Migraine

Neurologic Clinics

Volumn 27, Issue 2, 2009, Pages 361-378

  Foroozan, Rod ^a   Cutrer, F Michael ^b  

^a CULLEN EYE INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Aura; Genetics; Migraine; Pathophysiology; Persistent aura; Retinal migraine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICONVULSIVE AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ERGOTAMINE DERIVATIVE; ESTROGEN RECEPTOR; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN TRANSPORTER; VALPROIC ACID;

CHOROID DISEASE; CLINICAL FEATURE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUSEN; EPIGENETICS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEMIPLEGIC MIGRAINE; HEREDITY; HOMONYMOUS HEMIANOPIA; HUMAN; ISCHEMIC OPTIC NEUROPATHY; LANGUAGE AURA; LANGUAGE DISABILITY; MIGRAINE AURA; MODULATION; MOTOR DYSFUNCTION; NERVE CELL EXCITABILITY; NEUROIMAGING; NEUROLOGIC DISEASE; NEW DAILY PERSISTENT HEADACHE; NONHUMAN; OPTIC DISC EDEMA; OPTIC NERVE DISEASE; PAPILLITIS; PATHOPHYSIOLOGY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINAL MIGRAINE; RETINOPATHY; REVIEW; SENSORY AURA; SENSORY DYSFUNCTION; SIDE EFFECT; STROKE; VASOSPASM; VISUAL AURA; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

HUMANS; MIGRAINE DISORDERS; MIGRAINE WITH AURA; OPTIC DISK DRUSEN; OPTIC NEUROPATHY, ISCHEMIC; PROGNOSIS; STROKE; SYNDROME; TIME FACTORS; VISION DISORDERS;

EID: 61849119054     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.11.002     Document Type: Review

References (95)

1. International classification of headache disorders, 2nd edition. Cephalalgia 2004;24:1-160.
2. Eriksen M.K., Thomsen L.L., and Olesen J. Sensitivity and specificity of the new international diagnostic criteria for migraine with aura. J Neurol Neurosurg Psychiatr 76 2 (2005) 212-217
3. Cutrer F.M., and Huerter K. Migraine aura. Neurologist 13 3 (2007) 118-125
4. Russell M.B., and Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 119 (1996) 335-361
5. Russell M.B., Iversen H.K., and Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia 14 (1994) 107-117
6. Carlow T.J. Oculomotor ophthalmoplegic migraine: is it really migraine?. J Neuroophthalmol 22 3 (2002) 215-221
7. Hupp S.L., Kline L.B., and Corbett J.J. Visual disturbances of migraine. Surv Ophthalmol 33 4 (1989) 221-236
8. Spector R.H. Migraine. Surv Ophthalmol 29 3 (1984) 193-207
9. Evans R.W., and Rolak L.A. The Alice in Wonderland syndrome. Headache 44 6 (2004) 624-625
10. Vincent M.B., and Hadjikhani N. Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia 27 12 (2007) 1368-1377
11. Schott G.D. Exploring the visual hallucinations of migraine aura: the tacit contribution of illustration. Brain 130 Pt 6 (2007) 1690-1703
12. Liu G.T., Schatz N.J., Galetta S.L., et al. Persistent positive visual phenomena in migraine. Neurology 45 4 (1995) 664-668
13. San-Juan O.D., and Zermeno P.F. Migraine with persistent aura in a Mexican patient: case report and review of the literature. Cephalalgia 27 5 (2007) 456-460
14. Cupini L.M., and Stipa E. Migraine aura status and hyperhomocysteinaemia. Cephalalgia 27 7 (2007) 847-849
15. Jager H.R., Giffin N.J., and Goadsby P.J. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 25 5 (2005) 323-332
16. Relja G., Granato A., Ukmar M., et al. Persistent aura without infarction: description of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 25 1 (2005) 56-59
17. Bereczki D., Kollar J., Kozak N., et al. Cortical spreading edema in persistent visual migraine aura. Headache 48 8 (2008) 1226-1229
18. Rothrock J.F. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 48 1 (1997) 261-262
19. Chen W.T., Fuh J.L., Lu S.R., et al. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 41 8 (2001) 823-825
20. Narita A.S., and Elder J.E. Ocular migraine in an eight-year-old girl. Aust N Z J Ophthalmol 22 4 (1994) 275-277
21. Katz B. Bilateral sequential migrainous ischemic optic neuropathy. Am J Ophthalmol 99 4 (1985) 489
22. Katz B., and Bamford C.R. Migrainous ischemic optic neuropathy. Neurology 35 1 (1985) 112-114
23. O'Hara M., and O'Connor P.S. Migrainous optic neuropathy. J Clin Neuroophthalmol 4 2 (1984) 85-90
24. McDonald W.I., and Sanders M.D. Migraine complicated by ischaemic papillopathy. Lancet 2 7723 (1971) 521-523
25. Weinstein J.M., and Feman S.S. Ischemic optic neuropathy in migraine. Arch Ophthalmol 100 7 (1982) 1097-1100
26. Lana-Peixoto M.A., and Barbosa A. Anterior ischaemic optic neuropathy in a child with AS haemoglobinopathy and migraine. Br J Ophthalmol 82 2 (1998) 199-200
27. Lee A.G., Brazis P.W., and Miller N.R. Posterior ischemic optic neuropathy associated with migraine. Headache 36 8 (1996) 506-510
28. Foroozan R., Marx D.P., and Evans R.W. Posterior ischemic optic neuropathy associated with migraine. Headache 48 7 (2008) 1135-1139
29. Chiari M., Manzoni G.C., and Van de Geijn E.J. Ischemic optic neuropathy after sumatriptan in a migraine with aura patient. Headache 34 4 (1994) 237-238
30. Sommer S., Delemazure B., Wagner M., et al. [Bilateral ischemic optic neuropathy secondary to acute ergotism]. J Fr Ophtalmol 21 2 (1998) 123-125
31. Wollensak J., and Grajewski O. [Bilateral vascular papillitis following ergotamin medication]. [author's transl]. Klin Monatsbl Augenheilkd 173 5 (1978) 731-737
32. Auw-Haedrich C., Staubach F., and Witschel H. Optic disk drusen. Surv Ophthalmol 47 6 (2002) 515-532
33. Wilkins J.M., and Pomeranz H.D. Visual manifestations of visible and buried optic disc drusen. J Neuroophthalmol 24 2 (2004) 125-129
34. Gaynes P.M., and Towle P.A. Hemorrhage in hyaline bodies (drusen) of the optic disc during an attack of migraine. Am J Ophthalmol 63 6 (1967) 1693-1696
35. Ramirez H., Blatt E.S., and Hibri N.S. Computed tomographic identification of calcified optic nerve drusen. Radiology 148 1 (1983) 137-139
36. Newman N.J., Lessell S., and Brandt E.M. Bilateral central retinal artery occlusions, disk drusen, and migraine. Am J Ophthalmol 107 3 (1989) 236-240
37. Bousser M.G., Baron J.C., Iba-Zizen M.T., et al. Migrainous cerebral infarction: a tomographic study of cerebral blood flow and oxygen extraction fraction with the oxygen-15 inhalation technique. Stroke 11 2 (1980) 145-153
38. Robinson B.E. Permanent homonymous migraine scotomata. AMA Arch Ophthalmol 53 4 (1954) 566-567
39. Wakakura M., and Ichibe Y. Permanent homonymous hemianopias following migraine. J Clin Neuroophthalmol 12 3 (1992) 198-202
40. Carroll D. Retinal migraine. Headache 10 1 (1970) 9-13
41. Lepore F.E. Retinal migraine. J Neuroophthalmol 27 3 (2007) 242-243 author reply 4-5
42. Evans R.W., and Grosberg B.M. Retinal migraine: migraine associated with monocular visual symptoms. Headache 48 1 (2008) 142-145
43. Grosberg B.M., Solomon S., Friedman D.I., et al. Retinal migraine reappraised. Cephalalgia 26 11 (2006) 1275-1286
44. Doyle E., Vote B.J., and Casswell A.G. Retinal migraine: caught in the act. Br J Ophthalmol 88 2 (2004) 301-302
45. Glenn A.M., Shaw P.J., Howe J.W., et al. Complicated migraine resulting in blindness due to bilateral retinal infarction. Br J Ophthalmol 76 3 (1992) 189-190
46. Pandit J.C., and Fritsche P. Permanent monocular blindness and ocular migraine. J R Soc Med 90 12 (1997) 691-692
47. Grosberg B.M., and Solomon S. Retinal migraine: two cases of prolonged but reversible monocular visual defects. Cephalalgia 26 6 (2006) 754-757
48. Solomon S., Grosberg B.M., Friedman D.I., et al. Retinal migraine. J Neuroophthalmol 27 3 (2007) 243-244 author reply 4-5
49. Winterkorn J.M. "Retinal migraine" is an oxymoron. J Neuroophthalmol 27 1 (2007) 1-2
50. Daroff R.B. Retinal migraine. J Neuroophthalmol 27 1 (2007) 83
51. Hill D.L., Daroff R.B., Ducros A., et al. Most cases labeled as "retinal migraine" are not migraine. J Neuroophthalmol 27 1 (2007) 3-8
52. Winterkorn J.M., Kupersmith M.J., Wirtschafter J.D., et al. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 329 6 (1993) 396-398
53. Robertson D.M. I am a retinal migraineur. J Neuroophthalmol 28 1 (2008) 81-82
54. Ebner R. Visual field examination during transient migrainous visual loss. J Clin Neuroophthalmol 11 2 (1991) 114-117
55. McKendrick A.M., Vingrys A.J., Badcock D.R., et al. Visual dysfunction between migraine events. Invest Ophthalmol Vis Sci 42 3 (2001) 626-633
56. Lewis R.A., Vijayan N., Watson C., et al. Visual field loss in migraine. Ophthalmology 96 3 (1989) 321-326
57. McKendrick A.M., Vingrys A.J., Badcock D.R., et al. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci 41 5 (2000) 1239-1247
58. Drummond P.D., and Anderson M. Visual field loss after attacks of migraine with aura. Cephalalgia 12 6 (1992) 349-352
59. McKendrick A.M., and Badcock D.R. Decreased visual field sensitivity measured 1 day, then 1 week, after migraine. Invest Ophthalmol Vis Sci 45 4 (2004) 1061-1070
60. McKendrick A.M., and Badcock D.R. An analysis of the factors associated with visual field deficits measured with flickering stimuli in between migraine. Cephalalgia 24 5 (2004) 389-397
61. Yenice O., Temel A., Incili B., et al. Short-wavelength automated perimetry in patients with migraine. Graefes Arch Clin Exp Ophthalmol 244 5 (2006) 589-595
62. Tibber M.S., and Shepherd A.J. Transient tritanopia in migraine: evidence for a large-field retinal abnormality in blue-yellow opponent pathways. Invest Ophthalmol Vis Sci 47 11 (2006) 5125-5131
63. Corbett J.J., Phelps C.D., Eslinger P., et al. The neurologic evaluation of patients with low-tension glaucoma. Invest Ophthalmol Vis Sci 26 8 (1985) 1101-1104
64. Lord G.D.A. Clinical characteristics of the migrainous aura. In: Amery W.K., and Wauquier A. (Eds). The prelude to the migraine attack (1986), Baillière Tindall, London 87-98
65. Kurth T., Schürks M., Logroscino G., et al. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337 (2008) a636
66. Fisher C.M. Late-life migraine accompaniments: further experience. Stroke 17 (1986) 1033-1042
67. Bradshaw P., and Parsons M. Hemiplegic migraine, a clinical study. QJM 34 (1965) 3465-3485
68. Leao A.A.P. Spreading depression of activity in the cerebral cortex. J Neurophysiol 7 (1944) 359-390
69. Milner P. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. Electroencephalogr Clin Neurophysiol 10 (1958) 705
70. Olesen J., Larsen B., and Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9 (1981) 344-352
71. Lauritzen M., Skyhoj Olsen T., Lassen N.A., et al. Changes of regional cerebral blood flow during the course of classical migraine attacks. Ann Neurol 13 (1983) 633-641
72. Cutrer F.M., Sorensen A.G., Weisskoff R.M., et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 43 1 (1998) 25-31
73. Sorensen A.G., and Rosen B.R. Functional MRI of the brain. In: Atlas S. (Ed). Magnetic resonance imaging of the brain and spine. 2nd edition (1996), Lippcott-Raven Publishers, Philadelphia
74. Hadjikhani N., Sanchez Del Rio M., Wu O., et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98 8 (2001) 4687-4692
75. James M.F., Smith M.I., Bockhorst K.H., et al. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol 519 Pt 2 (1999) 415-425
76. Smith M., Cros D., and Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 58 8 (2002) 1308-1310
77. Gekeler F., Holtmannspotter M., Straube A., et al. Diffusion-weighted magnetic resonance imaging during the aura of pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis. Headache 42 4 (2002) 294-296
78. Welch K.M.A., Levine S.R., D'Andrea G., et al. Brain pH during migraine studied by in-vivo 31-phosphorus NMR spectroscopy. Cephalalgia 8 (1988) 273-277
79. Welch K.M.A., Levine S.R., D'Andrea G., et al. Preliminary observations on brain energy metabolites in migraine studied by in vivo 31-phosphorus NMR spectroscopy. Neurology 39 (1989) 538-541
80. Welch K.M.A., Barkley G.L., Ramadan N.M., et al. NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis. Pathol Biol 40 4 (1992) 349-354
81. van Harreveld A., and Fifekova E. Mechanisms involved in spreading depression. J Neurobiol 4 (1973) 375-387
82. Sandor P.S., Dydak U., Schoenen J., et al. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia 25 7 (2005) 507-518
83. Ambrosini A., de Noordhout A.M., Sandor P.S., et al. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia 23 Suppl 1 (2003) 13-31
84. Aurora S.K., Welch K.M., and Al-Sayed F. The threshold for phosphenes is lower in migraine. Cephalalgia 23 4 (2003) 258-263
85. Lea R.A., Nyholt D.R., Curtain R.P., et al. A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine. Neurogenetics 6 2 (2005) 67-72
86. Kara I., Sazci A., Ergul E., et al. Association of the C677T and A1298C polymorphisms in the 5,10 Methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111 1-2 (2003) 84-90
87. Wessman M., Kallela M., Kaunisto M.A., et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 70 (2002) 652-662
88. Carlsson A., Forsgren L., Nylander P.-O., et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1. Neurology 59 (2002) 1804-1807
89. Colson N., Lea R., Quinlan S., et al. The estrogen receptor 1G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 5 (2004) 129-133
90. Colson N., Lea R., Quinlan S., et al. Investigation of hormone receptor genes in migraine. Neurogenetics 6 (2005) 17-23
91. Peroutka S.J., Price S.C., and Wilhoit T.L. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4 1 (1998) 14-21
92. Peroutka S.J., Wilhoit T., and Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49 1 (1997) 201-206
93. Cader Z.M., Noble-Topham S., Dyment D.A., et al. Significant linkage to migraine with aura on chromosome 11q24. Hum Mol Genet 12 19 (2003) 2511-2517
94. Russo L., Mariotti P., Sangiorgi E., et al. A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Genet 76 2 (2005) 327-333
95. Ogilvie A.D., Russell M.B., and Dhall P. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 18 1 (1998) 23-26